Cary Street Partners Investment Advisory LLC Bristol Myers Squibb CO Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

A detailed history of Cary Street Partners Investment Advisory LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 46,235 shares of BMY stock, worth $2.68 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

46,235

Previous 89,918 48.58%

Holding current value

$2.68 Million

Previous $3.73 Million 35.94%

% of portfolio

0.09%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$39.66 - $51.75 $1.73 Million - $2.26 Million	-43,683 Reduced 48.58%	46,235 $2.39 Million
Q2 2024 Jul 22, 2024	SELL	$40.25 - $52.99 $133,348 - $175,555	-3,313 Reduced 3.55%	89,918 $3.73 Million
Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $237,357 - $269,116	-4,947 Reduced 5.04%	93,231 $5.06 Million
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $3.58 Million - $4.27 Million	73,744 Added 301.81%	98,178 $5.04 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $4.04 Million - $4.82 Million	-83,306 Reduced 77.32%	24,434 $1.25 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $418,602 - $468,062	7,231 Added 7.19%	107,740 $6.25 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $297,270 - $330,072	-4,666 Reduced 4.44%	100,509 $6.43 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $168,349 - $190,945	2,562 Added 2.5%	105,175 $7.29 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $48,483 - $57,411	-708 Reduced 0.69%	102,613 $7.38 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $86 - $51,175	666 Added 0.65%	103,321 $7.35 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $4.57 Million - $5.04 Million	62,989 Added 158.8%	102,655 $7.91 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $936,463 - $1.12 Million	15,232 Added 62.34%	39,666 $2.9 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $87,309 - $101,782	1,628 Added 7.14%	24,434 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $121,357 - $142,154	2,051 Added 9.88%	22,806 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $637,982 - $694,763	10,305 Added 98.61%	20,755 $1.39 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $908,198 - $1.02 Million	-15,305 Reduced 59.43%	10,450 $660,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $3.14 Million - $3.56 Million	-54,382 Reduced 67.86%	25,755 $1.6 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $4.35 Million - $4.82 Million	75,754 Added 1728.36%	80,137 $4.83 Million
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $10,904 - $15,846	235 Added 5.67%	4,383 $244,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $204,123 - $266,260	4,148 New	4,148 $266,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account

Cary Street Partners Investment Advisory LLC Bristol Myers Squibb CO Transaction History